Skip to main content
Future Journal of Pharmaceutical Sciences
Download PDF

Amelioration of complete Freund’s adjuvant-induced arthritis by Calotropis procera latex in rats

Future Journal of Pharmaceutical Sciences volume 7, Article number: 213 (2021) Cite this article

Abstract

Background

Rheumatoid arthritis is the most common cause of disability, affecting 0.3–1% of the adult population worldwide. The latex of Calotropis procera possesses potent anti-inflammatory as well as analgesic properties. In light above facts, the present study was designed to evaluate anti-arthritic activity of Calotropis procera latex in complete Freund's adjuvant (CFA)-induced arthritis in Wistar albino rats. Complete Freund's adjuvant was injected into the left hind paw on day 0, and treatment of prednisolone and Calotropis procera latex was given from day 0 to 28. Various biochemical, hematological and functional parameters as well as radiological and histopathological changes of joint along with body weight and paw volume were measured.

Results

Calotropis procera treatment significantly lowered paw volume in CFA-induced arthritic rats. Significant improvement was observed in functional, biochemical and hematological parameters in Calotropis procera-treated rats. However, the body weight remained unaffected. Histological and radiographical examination of synovial joints in Calotropis procera-treated animals exhibited less synovial hyperplasia, infiltration and accumulation of inflammatory cell in synovial fluid, cartilage and bone erosion and joint space narrowing.

Conclusion

Calotropis procera latex possesses anti-arthritic activity, which is facilitated by modulation in the level of inflammatory mediators and oxidative stress. The improvement in hematological as well as biochemical parameters might be reflected on functional, histopathological, radiological changes and thereby disease progression.

Background

Rheumatoid arthritis (RA) is chronic inflammatory-erosive disorder of joints. The worldwide prevalence of the disease is 0.3–1%, and women are more prone to develop the disease than men [1]. It is characterized with swelling, pain and morning stiffness and predominantly involved small joints of the wrist, hands, feet and knee [2]. Disease progresses with joint erosion, muscle atrophy, loss of mobility and systemic manifestation, affecting individual’s daily living activities as well as psychological health [3, 4].

It is well known that the pro-inflammatory cytokines like interleukins 1 (IL-1), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) are responsible for auto-immunity, chronic inflammation and joint damage [5]. Many pre-clinical and clinical studies revealed elevated level of these cytokines in the serum and synovial fluid in patients with RA [6,7,8]. The cytokines-mediated joint damage occurs by stimulation of mesenchymal cells like synovial fibroblasts, osteoclasts, chondrocytes and thereby release of tissue-destroying matrix metalloproteinases. The production of metalloproteinases tissue inhibitor by synovial fibroblast is also repressed by cytokines [9]. Along with this, nitric oxide (NO) mediates synovial inflammation by angiogenic cytokine production, matrix metalloproteinases activation and apoptosis [10]. Current medications such as disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids and TNF inhibitor have high cost and serious adverse effects [11]. Moreover, 30% patients did not show significant improvement with these treatments [12]. Thus, alternative therapy with herbal medicine, effective in alleviating rheumatic pain with minimum side effects is required.

Calotropis procera is an Indian tropical plant with important medicinal properties like anti-diabetic [13], hepatoprotective [14], anti-oxidant [15], anti-pyretic [16] and anti-fertility [17] activity. Molecular docking of few phytochemicals present in the latex of Calotropis procera has been reported to exhibit potent anti-inflammatory and analgesic activity [18,19,20]. Also, the latex of Calotropis procera significantly reduces cell influx, inflammatory mediators, oxidative stress and thereby improves locomotor dysfunction in complete Freund's adjuvant (CFA)-induced arthritic rats [21, 22]. In light of these facts, the present study was carried out to evaluate the effect of dry latex of Calotropis procera in CFA-induced arthritis in rats.

Methods

Materials

Complete Freund’s adjuvant was purchased from Sigma-Aldrich, USA (F5881), and prednisolone was purchased from Macleods Pharmaceuticals Ltd., Gujarat, India. Analytical grade chemicals and reagents were used throughout the experiment. Rheumatoid factor (RF) and C-reactive protein (CRP) were measured using diagnostic kits obtained from Beacon Diagnostics Pvt. Ltd., Gujarat, India. The plasma TNF-α and IL-6 were measured with rat ELISA kits purchased from Genxbio health sciences, Delhi, India.

Animals

The animals (procured from in-house animal facility) were kept in standard polypropylene cages (three rats/cage) and maintained at 22 ± 2 ◦C temperature and 55 ± 5% humidity, with 12/12-h light and dark cycle. All the rats were fed with commercially available rat normal pellet diet (NPD) and given water ad libitum. The experimental protocol (KBIPER/17/596) was approved by the Institutional Animal Ethics Committee, Gujarat, India.

Plant materials and drugs

The identification and authentication of C. procera was done by Pharmacognosy Department of KBIPER, and voucher specimen was preserved. The fresh latex was collected from the aerial parts of the plant growing in the wild. Thereafter, the latex was lyophilized, triturated with gum acacia, filtered and administered.

Experimental design

The adult female Wistar rats weighing 200–250 g were randomized (based on body weight) into four groups (n = 6).

  • Group I—Normal control (NC) group

  • Group II—CFA-induced arthritic (DC) group

  • Group III—Prednisolone-treated (PS10) group (10 mg/kg, p.o.)

  • Group IV—Dry latex of C. procera (DL250)-treated group (250 mg/kg, p.o.)

Arthritis was induced in rats as per the procedure described by Gohil et al. [23]. Briefly, for induction of arthritis, 0.2 ml CFA (containing 10 mg/ml of heat-killed M. tuberculosis) was injected into left hind paw of all the animals except group I. One hour before the injection of CFA, group III and group IV animals were administered prednisolone and C. procera treatment, respectively, from day 0 and continued till day 28, whereas normal control and disease control animals received 0.1 ml vehicle only.

Paw volume

The left hind paw volume was measured weekly from day 0 to day 28 using digital plethysmometer (Orchid Scientific & Innovative India Pvt Ltd., Maharashtra, India) from all groups.

Blood collection, hematological and biochemical estimation

At the end of study, blood samples were collected under pentobarbital (60 mg/kg, i.p.) anesthesia into EDTA-coated tubes and used for measurement of hemoglobin (Hb), total white blood cell (WBC) count, red blood cell (RBC) count and erythrocyte sedimentation rate (ESR).

Thereafter, blood was centrifuged at 5,000 RPM, 4ºC for 10 min (REMI, Germany) and separated plasma was used for biochemical estimation like rheumatoid factor (RF), C-reactive protein (CRP), TNF-α and IL-6. Nitrite level was measured by Griess reagent system [24].

Joint stiffness

Joint stiffness was measured as per score described by Nagakura et al. [25] at the end of the study. The rat was held from back with left palm, and the bending and extension of limbs in each direction were performed within the limits of motion with right fingers. Score 2: restriction of both bending and extension movement of ankle, Score 1: restriction of either bending or extension movement of ankle score 0: no restriction of ankle movement (Table 1).

Table 1 Scoring system for arthritic index
Full size table

Mobility test

On day 28, mobility score was performed as mentioned below—Score 6: animal walks normally, score 5: ipsilateral hind paw of the animal fully the floor, score 4: only toe of the ipsilateral hind paw of the animal touches the floor, score 3: fully touches the contralateral hind paw and fully touches the floor, score 2: only toe of the contralateral hind paw of the animal touches the floor, score 1: animal only crawls with fore limbs, score 0: animal does not move [25].

Gait test

At the end of the study, rats from each group were allowed to move freely on a table top for gait test. Score 2: creeping behavior (moving on the two fore limbs, dragging the two hind limbs), score 1: inactive use of paw to support the body, score 0: active use [25]. Adjuvant-treated paw was overlooked for gait score because swelling and abscess formation were observed in several animals (Table 2).

Table 2 Scoring system for visual weight-bearing test
Full size table

Arthritic index

Two observers blinded with study were observed ears, nose, tail, forepaws and hind paws for the presence of inflammation and/or nodules. Arthritic index was calculated according to the scoring system of Bartlett and Schleyerbach, 1985 [26] (Table 1), and results are given in Table 3.

Table 3 Effect of C. procera on functional parameters of CFA-induced arthritic rats
Full size table

Visual weight-bearing test

For visual weight-bearing test, both paws of rats were dipped in ink and their walkway pattern on paper was scored [27]. The scoring system is shown in Table 2 and the results are shown in Table 4.

Table 4 Effect of C. procera on biochemical parameters of CFA-induced arthritic rats
Full size table

Histopathology and X-ray analysis of left hind limb joint

On day 28, rats were anesthetized using pentobarbital (60 mg/kg, i.p.) and subjected to X-ray examination of the left hind legs. Thereafter, the rats were killed; left hind limb joints were collected and stored in 10% formalin. Formalin-fixed tissue was dehydrated, embedded in paraffin wax and sectioned. The sections were stained with hematoxylin–eosin and examined for cartilage destruction, synovial space, hyperplasia of tissue and bone erosion.

Statistical analysis

All data are expressed as mean ± SEM. The data were subjected for statistical analysis using GraphPad Prism 5.0 (CA, USA). The statistical significance of difference between various groups was tested by one-factor analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. The results of body weight and paw edema were assessed by two-way ANOVA and Bonferroni’s post hoc test. In each test, p < 0.05 was considered statistically significant.

Results

Effect of C. procera on body weight

Compared to control rats, CFA-induced arthritic rats showed a significant decrease in body weight. Prednisolone treatment and C. procera treatment did not show significant change in body weight as compared to CFA-induced arthritic rats. However, the body weight was slightly higher in C. procera-treated rats than prednisolone-treated rats (Fig. 1).

Fig. 1
figure 1

Effect of C. procera on body weight of CFA-induced arthritic rats. Data represented as mean ± SEM; *p < 0.05 compared to NC group (two-way ANOVA followed by Bonferroni’s post hoc test). NC normal control group, DC CFA-induced arthritic group, PS10 prednisolone-treated group, DL250 dry latex of C. procera-treated group

Full size image

Effect of C. procera on paw volume

A linear increase in paw volume was observed in CFA-induced arthritic rats compared to control rats throughout the experiment. Both prednisolone treatment and C. procera treatment showed significantly lower paw volume compared to CFA-induced arthritic rats. Moreover, the paw volume was similar in prednisolone-treated rats and C. procera-treated rats (Fig. 2).

Fig. 2
figure 2

Effect of C. procera on left hind paw volume of CFA-induced arthritic rats. Data represented as mean ± SEM; *p < 0.05 compared to NC group; #p < 0.05 compared to DC group (two-way ANOVA followed by Bonferroni’s post hoc test). NC normal control group, DC CFA-induced arthritic group, PS10 prednisolone-treated group, DL250 dry latex of C. procera-treated group

Full size image

Effect of C. procera on gait test, mobility test, joint stiffness and visual weight-bearing test

Functional parameters like gait test, mobility test, joint stiffness and visual weight-bearing test significantly differ between CFA-induced arthritic rats and control rats. Further, in prednisolone-treated rats as well as in C. procera-treated rats, significant improvement was observed in all these parameters (Table 3).

Effect of C. procera on arthritic index

There was a significant increase in the arthritic index after CFA administration. Prednisolone-treated rats, as well as C. procera-treated rats, showed significantly lower arthritic index compared with CFA-induced arthritic rats (Fig. 3).

Fig. 3
figure 3

Effect of C. procera on the arthritic index of CFA-induced arthritic rats. Data represented as mean ± SEM; *p < 0.05 compared to NC group; #p < 0.05 compared to DC group (two-way ANOVA followed by Bonferroni’s post hoc test). NC normal control group, DC CFA-induced arthritic group, PS10 prednisolone-treated group, DL250 dry latex of C. procera-treated group

Full size image

Effect of C. procera on biochemical parameters

In comparison with control rats, biochemical parameters like IL-6, TNF-α, RF factor, CRP and nitrite levels were significantly elevated in CFA-induced arthritic rats. The treatment with prednisolone significantly restores all biochemical parameters. C. procera treatment significantly lowered IL-6, RF factor, CRP and nitrite levels without altering TNF-α level (Table 4).

Effect of C. procera on hematological parameters

In CFA-induced arthritic rats, significantly lower Hb level and RBC count, as well as higher ESR and total WBC count, was observed in comparison with control rats. Both prednisolone and C. procera significantly restored all these hematological changes (Table 5).

Table 5 Effect of C. procera on hematological parameters of CFA-induced arthritic rats
Full size table

Effect of C. procera on histopathological changes of synovial joint

The histopathological changes of tarsotibial joints from different animal groups are shown in Fig. 4. In control rats, synovial lining showed a thin layer of flat and quiescent cells and normal synovial space. No leucocyte infiltration or bone erosion was observed. Complete Freud's adjuvant-induced arthritic rats showed proliferation of synovial membrane cells which formed a thick and multilayered synovial cell lining and reduced synovial space. In addition, diffused infiltration of synovial inflammatory cells, pannus formation in focal areas and new blood vessels formation in inflammatory synovial tissue were also observed. Prednisolone-treated and C. procera-treated group exhibited less synovial hyperplasia, infiltration and accumulation of inflammatory cell in synovial fluid, cartilage and bone erosion and joint space narrowing in comparison with CFA-induced arthritic group.

Fig. 4
figure 4

Histological sections (40 ×) of tarsotibial joints of left hind paw form different animal groups. A Control group showed normal synovial space (S), articular cartilage (CT), bone structure (BN) and absence of inflammatory cells; B CFA-induced arthritic group showed marked infiltration of inflammatory cells, synovial hyperplasia and marked reduction in synovial joint (shown by arrow); C prednisolone-treated group and D dry latex of C. procera-treated group showed less inflammatory cell infiltration, minimal synovial hyperplasia and modest reduction in joint space

Full size image

Effect of C. procera on X-ray radiographic changes of synovial joint

As shown in Fig. 5, X-ray radiography of tarsotibial joints of left hind legs was performed to evaluate the effect of C. procera on CFA-induced arthritic rats. The control rats demonstrated the normal structure of joints and bone. Complete Freud's adjuvant-induced rats displayed arthritic changes like excessive soft tissue swelling, joint space narrowing and bone erosion. The bones were seen unprotected by cartilage. Prednisolone treatment and C. procera treatment exhibited an inhibitory effect on swelling and bone erosion.

Fig. 5
figure 5

X-ray radiographic of tarsotibial joints of hind legs from different animal groups. A Control rats show a normal structure of joint; B CFA-induced arthritic rats show swelling of soft tissue on left hind paw (arrow), joint destruction, bone erosion and deformities; C prednisolone-treated group D and dry latex of C. procera-treated group show less soft tissue swelling, reduced bone destruction with normal space in joint

Full size image

Discussion

Rheumatoid arthritis affects billions of people worldwide and, thus, the most common cause of disability. The potential side effects of presently available treatment enforce to identify more effective therapy that will benefit a wide range of patients. From last few years, herbal products are gaining more attention for the prevention and treatment of many diseases. The reports suggesting anti-inflammatory and analgesic activities of C. procera were considered for the present to investigate its effect in arthritic rats.

Complete Freund's adjuvant-induced arthritis is commonly used murine model of chronic polyarthritis. The pathophysiological changes like synovial hyperplasia and cartilage degradation observed in this model are similar to clinical arthritis [28]. More importantly, this model is more relevant for the evaluation of anti-inflammatory as well as the analgesic potential of drugs [29]. Though the female rats show variability in disease onset and severity in CFA-induced arthritis [30], female rats are more susceptible for development of disease as compared to male rats [31]. Hence, CFA-induced arthritic model in female rats was used in the present study. In CFA-induced arthritic rats, T cells are infiltrated from spleen, Peyer’s patches and lymph nodes in the inflamed joints. This immune response was induced by specific antigen heat-shock protein (Hsp65). Along with this, various cytokines like IL-17, IFN and TNF-α seem to be expressed during early phase of inflammation. As the inflammation progresses, increased levels of IL-4, IL-6, monocyte chemotactic protein 1 and TGF-β can also be detected.

Rheumatoid cachexia is characterized by reduced muscle mass and weakness due to RA. About two-thirds of people with RA suffer from this complication. TNF-α and IL-1 are the key inflammatory cytokines involved in the pathogenesis of rheumatoid cachexia [32]. This cytokines are also found to be associated with higher rates of protein breakdown in RA patients as compared to healthy subjects [33]. Likewise, progressive decrease in body weight was also observed in CFA-induced arthritic rats [23, 34]. Similar results for body weight reduction in CFA-induced arthritic rats were also observed in the present study. Both prednisolone treatment, as well as C. procera treatment to arthritic rats, did not show improvement in the body weight. However, many researchers reported improvement in the body weight after prednisolone treatment [35, 36]. Contrary to this, other researcher reported a decrease in body weight after prednisolone treatment [37].

Swelling of paw is a simple and sensitive parameter for assessment of therapeutic efficacy of various anti-inflammatory drugs [38]. Paw volume was increased progressively in CFA-induced arthritic rats throughout the experiment, whereas it was reduced after 14 days in prednisolone-treated group and C. procera-treated group. Along with severe inflammation, arthritic animals also showed ulcer, pus formation and severe deformities in injected paw. As both treatments reduce inflammation, no such signs were observed in drug-treated animals (Fig. 6). It is believed that the change in paw volume is associated with activation of monocytes. These activated monocytes produce various pro-inflammatory cytokines including IL-1, IL-6, TNF-α and trigger the production of matrix metalloproteinases and acute phase protein. This may lead to the development of specific cellular and humoral immune responses [39,40,41]. An elevated level of inflammatory cytokines was observed in RA patients [42] as well as in experimentally induced arthritic rats [43]. Various in vivo and in vitro studies reported reduction in tissue TNF-α level [22, 44, 45]. Prednisolone treatment reduced both TNF-α and IL-6 levels in CFA-induced arthritic rats, whereas C. procera treatment affects only IL-6 level in CFA-induced arthritic rats.

Fig. 6
figure 6

Representative photographs of CFA-induced arthritic rats from different animal groups. A1 Control rats show both paws normal; B1 front view and B2 back view of left hind paw show severe inflammation, ulcer formation, pus formation and even deformities. B3 nodule in the eye (circle) indicates the extra-articular symptoms in CFA-induced arthritic rats; C1 front view and C2 back view of prednisolone-treated rats as well as (D1, D2) C. procera-treated rats show less inflammation and also no ulcer or pus formation

Full size image

Rheumatoid arthritis is a connective tissue disorder affecting para-articular structures and causes pain, stiffness and swelling of joints. This physical impairment can be evaluated by various functional parameters like gait test, mobility test, joint stiffness and visual weight-bearing test. As the disease progresses, it also involves extra-articular tissues like skin, eye, lung, heart, kidney, blood vessels and many more. In the present study, nodule formation in the eye of CFA-induced arthritic rats was observed (Fig. 6). The arthritic index is a secondary immune response which involves inflammation, nodule formation and dissemination of disease at non-injected sites [46]. It is used to evaluate disease progression and severity. The arthritic index was higher in CFA-induced arthritic rats. Likewise, other functional parameters like gait test, mobility test, joint stiffness and visual weight-bearing test were also altered in CFA-induced arthritic rats. Both prednisolone-treated group and C. procera-treated group showed improvement in all these functional parameters.

Hematological alterations like anemia of chronic disease, leukocytosis and rise in ESR exhibited by patients with active RA [47]. A moderate rise in the WBC count is mediated by IL-1β [48]. Studies also revealed that anemia occurs in chronic arthritic patients due to reduction in erythropoietin levels, a diminished response of the bone marrow erythropoietin and premature destruction of RBCs. Addition to this, higher ESR is associated with increase production of endogenous proteins such as fibrinogen and α/β globulin [49]. CFA-induced arthritic rats exhibited lower RBC count and Hb content, whereas higher WBC counts and ESR. Similar hematological changes in arthritic rats were reported by many researchers [50, 51]. C. procera treatment, as well as reference drug prednisolone treatment, exhibited a potent inhibitory effect on all hematological changes induced by CFA administration. The results exhibiting a beneficial effect of prednisolone in experimentally induced RA were supported by previous findings [52, 53].

Rheumatoid factor is an autoantibody, directed against the Fc region of IgG. The complex formation between RF and IgG is responsible for the development of RA [54]. Rheumatoid factor was found to be positive in approximately 80% of RA patients [55]. Similar to RF, CRP level is also recognized as an important non-specific inflammatory marker for RA. In this way, CRP level and RF measurement are valuable to understand the severity and disease progression in RA patients [56]. Contrary to prednisolone treatment and C. procera treatment group, higher CRP and RF level was observed in CFA-administered arthritic rats. A similar effect on CRP and RF levels after prednisolone treatment was also reported in arthritic rats [52] as well as in RA patients [57].

Further, there is growing evidence suggesting the role of NO in the pathogenesis of many autoimmune diseases including RA [58]. Preclinical studies reported a profound increase in NO level and restoration by selective inhibitors in experimentally induced arthritic animals [59, 60]. Further, the beneficial effects of NO synthesis inhibition inferred indirectly, with use of glucocorticoids, salicylates, indomethacin and methotrexate in RA patients [61, 62]. On the other hand, due to the short half-life and high reactivity, the routine assessment of NO levels in biological fluids is difficult. Therefore, NO concentration was measured indirectly in terms of nitrite [63]. In the present study, CFA-induced arthritic rats showed higher plasma nitrite level. The prednisolone and C. procera treatment significantly prevented the rise in nitrite level. One of the researchers reported that the treatment of non-dialyzable proteins of C. procera latex significantly decreases tissue level of nitrite [64].

Elevation of above biochemical markers reflected in histological changes of joints also. Control animals show the tarsotibial joints with no infiltration and bone erosion. However, the proliferation of synovial cell lining, reduced synovial space, pannus formation and new blood vessel formation ensued in CFA-induced arthritic rats. These histopathological changes in tarsotibial joints resemble with earlier studies [28, 65]. Prednisolone and C. procera treatment retards inflammatory cell infiltration and synovial hyperplasia. Thus, less bone destruction and joint space narrowing were observed as compared to CFA-induced arthritic rats. Earlier studies reported diminishing joint destruction by prednisolone treatment [52, 66] as well as C. procera treatment [21, 22] in arthritic rats.

Radiographic evaluation of joints is a useful diagnostic measure to indicate the severity of the disease. Primary radiographic change in RA is soft tissue swelling; thereafter, bone erosion and joint space narrowing were observed in a more advanced stage of arthritis [67]. Bone destruction, characterized by soft tissue swelling and loss of articular cartilage, was observed in CFA-induced arthritic rats, whereas control rats showed normal bony structure. These changes in arthritic rats were similar to previously reported radiographic changes [50, 68]. The standard drug prednisolone-treated group and C. procera-treated group showed delayed soft tissue swelling and cartilage destruction. Therefore, bony erosion in both of these treatment groups was less compared to the arthritic group. Combination of DMARD and low-dose prednisolone reduces disease progression in RA patients [69].

Conclusion

Calotropis procera latex possesses anti-arthritic activity, which is facilitated by modulation in the level of inflammatory mediators and oxidative stress. Moreover, the improvement was also observed in hematological parameters like Hb level, ESR, WBC and RBC count with the treatment that may be reflected in functional, histopathological, radiological changes and thereby disease progression. However, isolation of constituent of C. procera latex is required to understand its mechanism of anti-arthritic activity and to establish a more convincing rationale for clinical trials [70].

Availability of data and materials

Data and material are available upon request.

Abbreviations

CFA:

Complete Freund’s adjuvant

CRP:

C-reactive protein

DMARDs:

Disease-modifying anti-rheumatic drugs

ELISA:

Enzyme-linked immunosorbent assay

ESR:

Erythrocyte sedimentation rate

IL:

Interleukin

NO:

Nitric oxide

NPD:

Normal pellet diet

NSAIDs:

Non-steroidal anti-inflammatory drugs

RA:

Rheumatoid arthritis

RBC:

Red blood cell

RF:

Rheumatoid arthritis

TNF:

Tumor necrosis factor

WBC:

White blood cell

References

  1. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219. https://doi.org/10.1056/NEJMra1004965

    Article  CAS  PubMed  Google Scholar 

  2. Suresh E (2004) Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know. J R Soc Med 97:421–424. https://doi.org/10.1258/jrsm.97.9.421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cojocaru M, Cojocaru IM, Silosi I et al (2010) Extra-articular Manifestations in Rheumatoid Arthritis. Maedica (Buchar) 5:286–291

    Google Scholar 

  4. Fischer BD, Adeyemo A, Leary MEO, Bottaro A (2017) Animal models of rheumatoid pain: experimental systems and insights. Arthritis Res Ther 19:46–55. https://doi.org/10.1186/s13075-017-1361-6

    Article  CAS  Google Scholar 

  5. Houssiau FA (1995) Cytokines in rheumatoid arthritis. Clin Rheumatol 14:10–13

    Article  Google Scholar 

  6. Saxne T, Palladino MA, Heinegård D et al (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041–1045

    Article  CAS  Google Scholar 

  7. Moura RA, Cascao R, Perpetuo I et al (2010) Cytokine profile in serum and synovial fluid of patients with established rheumatoid arthritis. Ann Rheum Dis 69:A51–A51. https://doi.org/10.1136/ard.2010.129643g

    Article  Google Scholar 

  8. Paquet J, Goebel JC, Delaunay C et al (2012) Cytokines profiling by multiplex analysis in experimental arthritis: Which pathophysiological relevance for articular versus systemic mediators? Arthritis Res Ther 14:R60. https://doi.org/10.1186/ar3774

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Shingu M, Nagai Y, Isayama T et al (1993) The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 94:145–149

    Article  CAS  Google Scholar 

  10. van’t Hof RJ, Hocking L, Wright PK, Ralston SH, (2000) Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatology 39:1004–1008

    Article  Google Scholar 

  11. Jinesh S (2015) Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs. Inflammopharmacology 23:71–77. https://doi.org/10.1007/s10787-015-0229-0

    Article  CAS  PubMed  Google Scholar 

  12. Gutierrez-Rebolledo GA, Galar-Martnez M, Garcia-Rodriguez RV et al (2015) Antioxidant effect of Spirulina (Arthrospira) maxima on chronic inflammation induced by freund’s complete adjuvant in rats. J Med Food 18:865–871. https://doi.org/10.1089/jmf.2014.0117

    Article  PubMed  PubMed Central  Google Scholar 

  13. Roy S, Sehgal R, Padhy BM, Kumar VL (2005) Antioxidant and protective effect of latex of Calotropis procera against alloxan-induced diabetes in rats. J Ethnopharmacol 102:470–473. https://doi.org/10.1016/j.jep.2005.06.026

    Article  CAS  PubMed  Google Scholar 

  14. Qureshi AA, Prakash T, Patil T et al (2007) Hepatoprotective and antioxidant activities of flowers of Calotropis procera (Ait) R. Br. in CCl4 induced hepatic damage. Indian J Exp Biol 45:304–310

    PubMed  Google Scholar 

  15. Remya M, Ananthan R, Sivasankar S (2013) Antioxidant activity and analysis of polyphenols form the leaf extracts of Calotropis procera through ultra performance liquid chromatography. Int J Pharma Biol Sci 4:920–926

    Google Scholar 

  16. Dewan S, Kumar S, Kumar VL (2000) Antipyretic effect of latex of Calotropis procera. Indian J Pharmacol 32:252

    Google Scholar 

  17. Kamath JV, Rana AC (2002) Preliminary study on antifertility activity of Calotropis procera roots in female rats. Fitoterapia 73:111–115

    Article  Google Scholar 

  18. Arya S, Kumar VL (2005) Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation. Mediators Inflamm 2005:228–232. https://doi.org/10.1155/MI.2005.228

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sangraula H, Dewan S, Kumar VL (2002) Evaluation of anti-inflammatory activity of latex of Calotropis procera in different models of inflammation. Inflammopharmacology 9:257–264

    Article  Google Scholar 

  20. Talapatra SN, Talukdar P, Swarnakar S (2017) Interaction between C-reactive protein and phytochemicals from Calotropis procera: an approach on molecular docking. Int Lett Nat Sci 61:43–55

    Google Scholar 

  21. Kumar VL, Roy S (2009) Protective effect of latex of Calotropis procera in freund’s complete adjuvant induced monoarthritis. Phyther Res 23:1–5. https://doi.org/10.1002/ptr

    Article  CAS  Google Scholar 

  22. Kumar VL, Roy S (2007) Calotropis procera latex extract affords protection against inflammation and oxidative stress in freund’s complete adjuvant-induced monoarthritis in rats. Mediators Inflamm 2007:1–7. https://doi.org/10.1155/2007/47523

    Article  CAS  Google Scholar 

  23. Gohil P, Patel V, Deshpande S et al (2018) Anti-arthritic activity of cell wall content of Lactobacillus plantarum in freund’s adjuvant-induced arthritic rats: involvement of cellular inflammatory mediators and other biomarkers. Inflammopharmacology 26:171–181. https://doi.org/10.1007/s10787-017-0370-z

    Article  CAS  PubMed  Google Scholar 

  24. Bryan NS, Grisham MB (2008) Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 43:645–657

    Article  Google Scholar 

  25. Nagakura Y, Okada M, Kohara A et al (2003) Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306:490–497. https://doi.org/10.1124/jpet.103.050781

    Article  CAS  PubMed  Google Scholar 

  26. Bartlett RR, Schleyerbach R (1985) Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity—I. Disease modifying action on adjuvant arthritis of the rat. Int J Immunopharmacol 7:7–18. https://doi.org/10.1016/0192-0561(85)90003-7

    Article  CAS  PubMed  Google Scholar 

  27. Moller KA, Kinert S, Størkson R, Berge O (2012) Gait analysis in rats with single joint inflammation : influence of experimental factors. PLoS ONE 7:1–12. https://doi.org/10.1371/journal.pone.0046129

    Article  CAS  Google Scholar 

  28. Snekhalatha U, Anburajan M, Venkatraman B, Menaka M (2013) Evaluation of complete freund’s adjuvant-induced arthritis in a Wistar rat model: comparison of thermography and histopathology. J Rheumatol 72:375–382. https://doi.org/10.1007/s00393-012-1083-8

    Article  CAS  Google Scholar 

  29. Rajkapoor B, Kavimani S, Ravichandiran V et al (2009) Effect of Indigofera aspalathoides on complete freund’s adjuvant-induced arthritis in rats. Pharm Biol 47:553–557. https://doi.org/10.1080/13880200902902489

    Article  Google Scholar 

  30. Bendele A (2001) Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 377–385

  31. Gomes RP, Bressan E, da Silva TM et al (2013) Standardization of an experimental model suitable for studies on the effect of exercise on arthritis. Einstein 11:76–82. https://doi.org/10.1590/s1679-45082013000100014

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schaap LA, Pluijm SMF, Deeg DJH et al (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol Ser A Biol Sci Med Sci 64:1183–1189. https://doi.org/10.1093/gerona/glp097

    Article  CAS  Google Scholar 

  33. Rall LC, Rosen CJ, Dolnikowski G et al (1996) Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum 39:1115–1124

    Article  CAS  Google Scholar 

  34. Taksande BG, Gawande DY, Chopde CT et al (2017) Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats. Biomed Pharmacother 86:271–278. https://doi.org/10.1016/j.biopha.2016.12.039

    Article  CAS  PubMed  Google Scholar 

  35. Suke SG, Negi H, Mediratta PK et al (2013) Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis. Eur J Pharmacol 718:57–62. https://doi.org/10.1016/j.ejphar.2013.09.019

    Article  CAS  PubMed  Google Scholar 

  36. Du Y, Song Y, Zhang L et al (2016) Combined treatment with low dose prednisone and escin improves the anti-arthritic effect in experimental arthritis. Int Immunopharmacol 31:257–265. https://doi.org/10.1016/j.intimp.2016.01.006

    Article  CAS  PubMed  Google Scholar 

  37. Kuncha M, Naidu VGM, Sahu BD et al (2014) Curcumin potentiates the anti-arthritic effect of prednisolone in freund’s complete adjuvant-induced arthritic rats. J Pharm Pharmacol 66:133–144. https://doi.org/10.1111/jphp.12156

    Article  CAS  PubMed  Google Scholar 

  38. Kshirsagar AD, Panchal PV, Harle UN et al (2014) Anti-Inflammatory and antiarthritic activity of anthraquinone derivatives in rodents. Int J Inflam 2014:1–12

    Google Scholar 

  39. Thorbecke GJ, Shah R, Leu CH et al (1992) Involvement of endogenous tumor necrosis factor alpha and transforming growth factorbeta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 89:7375–7379

    Article  CAS  Google Scholar 

  40. Kweifio-Okai G, Carroll AR (1993) Antiarthritic effect of lupeol acetate. Phyther Res 7:213–215. https://doi.org/10.1002/ptr.2650070227

    Article  CAS  Google Scholar 

  41. Arend WP, Dayer JM (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305–315

    Article  CAS  Google Scholar 

  42. Kaneko M, Tomita T, Nakase T et al (2001) Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology 40:247–255

    Article  CAS  Google Scholar 

  43. Philippe L, Gegout-Pottie P, Guingamp C et al (1997) Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 273:1550–1556

    Google Scholar 

  44. Kumar VL, Sharma N, Cristina I et al (2014) Proteins derived from in vitro culture of the callus and roots of Calotropis procera ameliorate acute inflammation in the rat paw. Appl Biochem Biotechnol 175:1724–1731. https://doi.org/10.1007/s12010-014-1361-9

    Article  CAS  PubMed  Google Scholar 

  45. Padhy BM, Srivastava A, Kumar VL (2007) Calotropis procera latex affords protection against carbon tetrachloride induced hepatotoxicity in rats. J Ethnopharmacol 113:498–502. https://doi.org/10.1016/j.jep.2007.07.007

    Article  CAS  PubMed  Google Scholar 

  46. Dayer E, Dayer J-M, Roux-Lombard P (2007) Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat Clin Pract Rheumatol 3:512–520. https://doi.org/10.1038/ncprheum0572

    Article  CAS  PubMed  Google Scholar 

  47. Khurana R, Berney SM (2005) Clinical aspects of rheumatoid arthritis. Pathophysiol Off J Int Soc Pathophysiol 12:153–165. https://doi.org/10.1016/j.pathophys.2005.07.009

    Article  Google Scholar 

  48. Patil KR, Patil CR, Jadhav RB et al (2011) Anti-arthritic activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid-based Complement Altern Med 2011:1–7. https://doi.org/10.1093/ecam/nep148

    Article  Google Scholar 

  49. Hu F, Hepburn HR, Li Y et al (2005) Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J Ethnopharmacol 100:276–283. https://doi.org/10.1016/j.jep.2005.02.044

    Article  PubMed  Google Scholar 

  50. Ekambaram S, Perumal SS, Subramanian V (2010) Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund’s adjuvant induced arthritic rat model. BMC Complement Altern Med 10:56. https://doi.org/10.1186/1472-6882-10-56

    Article  PubMed  PubMed Central  Google Scholar 

  51. Patel MG, Pundarikakshudu K (2016) Anti-arthritic activity of a classical ayurvedic formulation vatari guggulu in rats. J Tradit Complement Med 6:389–394. https://doi.org/10.1016/j.jtcme.2015.08.007

    Article  PubMed  Google Scholar 

  52. Abdel El-Gaphar OAM, Abo-Youssef AM, Abo-Saif AA (2018) Effect of losartan in complete freund’s adjuvant -induced arthritis in rats. Iran J Pharm Res 17:1420–1430

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Matsuura M, Imayoshi T, Okumoto T (2000) Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int J Immunopharmacol 22:323–331

    Article  CAS  Google Scholar 

  54. Vinuesa CG, Sanz I, Cook MC (2009) Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 9:845–857. https://doi.org/10.1038/nri2637

    Article  CAS  PubMed  Google Scholar 

  55. Moore TL, Dorner RW (1993) Rheumatoid factors. Clin Biochem 26:75–84

    Article  CAS  Google Scholar 

  56. Scott DL (2000) Prognostic factors in early rheumatoid arthritis. Rheumatology 39:24–29

    Article  Google Scholar 

  57. den Uyl D, van Raalte DH, Nurmohamed MT et al (2012) Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction. Arthritis Rheum 64:639–646. https://doi.org/10.1002/art.33378

    Article  CAS  Google Scholar 

  58. Onur O, Akinci AS, Akbiyik F, Unsal I (2001) Elevated levels of nitrate in rheumatoid arthritis. Rheumatol Int 20:154–158

    Article  CAS  Google Scholar 

  59. Cannon GW, Openshaw SJ, Hibbs JB et al (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 39:1677–1684

    Article  CAS  Google Scholar 

  60. Rovenský J, Stančíková M, Rovenská E et al (2009) Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination. Ann N Y Acad Sci 1173:798–804. https://doi.org/10.1111/j.1749-6632.2009.04618.x

    Article  CAS  PubMed  Google Scholar 

  61. Weinberg JB, Lang T, Wilkinson WE et al (2006) Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures. Arthritis Res Ther 8:R140. https://doi.org/10.1186/ar2030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ersoy Y, Ozerol E, Baysal O et al (2002) Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann Rheum Dis 61:76–78. https://doi.org/10.1136/ARD.61.1.76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Odeh M (1997) New insights into the pathogenesis and treatment of rheumatoid arthritis. Clin Immunol Immunopathol 83:103–116

    Article  CAS  Google Scholar 

  64. Kumar VL, Guruprasad B, Chaudhary P et al (2015) Protective effect of proteins derived from Calotropis procera latex against acute inflammation in rat. Auton Autacoid Pharmacol 35:1–8. https://doi.org/10.1111/aap.12022

    Article  CAS  PubMed  Google Scholar 

  65. Liu J-Y, Hou Y-L, Cao R et al (2017) Protodioscin ameliorates oxidative stress, inflammation and histology outcome in complete freund’s adjuvant induced arthritis rats. Apoptosis 22:1454–1460. https://doi.org/10.1007/s10495-017-1420-0

    Article  CAS  PubMed  Google Scholar 

  66. Larsson E, Erlandsson Harris H, Larsson A et al (2004) Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology 43:428–434. https://doi.org/10.1093/rheumatology/keh073

    Article  CAS  PubMed  Google Scholar 

  67. Epstein FH, Harris ED (1990) Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 322:1277–1289. https://doi.org/10.1056/NEJM199005033221805

    Article  Google Scholar 

  68. Qian Y, Yu Y, Lv Y et al (2005) In vivo evaluation of early disease progression by X-ray phase-contrast imaging in the adjuvant-induced arthritic rat. Skeletal Radiol 35:156–164. https://doi.org/10.1007/s00256-005-0026-8

    Article  PubMed  Google Scholar 

  69. Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52:3371–3380. https://doi.org/10.1002/art.21421

    Article  CAS  PubMed  Google Scholar 

  70. Almarestani L, Fitzcharles M-A, Bennett GJ, Ribeiro-Da-Silva A (2011) Imaging studies in Freund’s complete adjuvant model of regional polyarthritis, a model suitable for the study of pain mechanisms, in the rat. Arthritis Rheum 63:1573–1581. https://doi.org/10.1002/art.30303

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are very thankful to Mr. Datal Nangal Chaudhry (Haryana, India), an innovator of this project.

Funding

This work was supported by grant from the BIRAC SRISTI appreciation award, under the Grass Root Innovation Scheme (Grant No.: BIRAC SRISTI PMU-2016/0019).

Author information

Authors and Affiliations

  1. Department of Pharmacology and Pharmacy Practice, K. B. Institute of Pharmaceutical Education and Research, Near GH-6 Circle, Sector-23, Gandhinagar, Gujarat, 382023, India

    Roshni Patel

  2. Department of Pharmacovigilance, Lambda Therapeutic Research Ltd., Ahmedabad, Gujarat, India

    Shahrukh Kadri, Priyanshee Gohil & Shrikalp Deshpande

  3. Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India

    Gaurang Shah

Authors
  1. Roshni Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahrukh Kadri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priyanshee Gohil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shrikalp Deshpande
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gaurang Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RP designed the study, analyzed the data, wrote the manuscript; SK executed the experiment and collected and analyzed the data; PG helped in study designing, manuscript editing, co-ordination; SD supervised the study; GS conceptualized and supervised the study. The author read and approved the final manuscript.

Corresponding author

Correspondence to Roshni Patel.

Ethics declarations

Ethics approval and consent to participate

The experimental protocol (KBIPER/17/596) was approved by the Institutional Animal Ethics Committee of K. B. Institute of Pharmaceutical Education and Research (KBIPER).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Patel, R., Kadri, S., Gohil, P. et al. Amelioration of complete Freund’s adjuvant-induced arthritis by Calotropis procera latex in rats. Futur J Pharm Sci 7, 213 (2021). https://doi.org/10.1186/s43094-021-00361-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43094-021-00361-w

Keywords

  • Latex
  • Calotropis procera
  • Rheumatoid arthritis
  • Complete Freund’s adjuvant
  • Functional parameters
  • ELISA
  • Anti-arthritic activity
  • Radiology